Insmed

+$1.57 (+7.91%) Today
$0.00 (0.00%) As of 9:42 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Insmed and other ETFs, options, and stocks.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.

CEO
William H. Lewis
Employees
613
Headquarters
Bridgewater, New Jersey
Founded
1988

INSM Key Statistics

Market cap
2.56B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.26M
High today
$21.50
Low today
$19.89
Open price
$20.10
Volume
2.17M
52 Week high
$34.44
52 Week low
$16.41

INSM News

Simply Wall StJun 24

Is Insmed A Risky Investment? - Simply Wall St

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural t

INSM Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure